LExpression of multiple sclerosis-associated retrovirus (MSRV)/HERV-W in MS patients and controls and comparison to that of Human Herpesvirus-6

被引：0
|
作者：
Mameli, Giuseppe
Serra, Caterina
Astone, Vito
Arru, Giannina
Bonetti, Bruno
机构：
[1] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy
[2] Univ Sassari, Inst Clin Neurol, I-07100 Sassari, Italy
[3] Univ Verona, Inst Clin Neurol, I-37100 Verona, Italy
来源：
JOURNAL OF NEUROVIROLOGY | 2004年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：39 / 40
页数：2
相关论文
共 46 条
  • [41] Ex vivo and in vitro expression of the neuroinflammatory endogenous protein MSRV-Env (Envelope protein of Multiple Sclerosis Associated Retrovirus) from human endogenous type W elements and interaction with Epstein-Barr virus in multiple sclerosis
    Morel, N.
    Germi, R.
    Casez, O.
    Epaulard, O.
    Grossi, L.
    Morand, L.
    Zaccaria, M.
    Perron, H.
    Morand, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 372 - 372
  • [42] Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls
    Tejada-Simon, MV
    Zang, YCQ
    Hong, J
    Rivera, VM
    Killian, JM
    Zhang, JWZ
    JOURNAL OF VIROLOGY, 2002, 76 (12) : 6147 - 6154
  • [43] Particle-associated retroviral RNA and tandem RGH HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis?
    Perron, H
    Perin, JP
    Rieger, F
    Alliel, PM
    JOURNAL OF NEUROVIROLOGY, 2000, 6 : S67 - S75
  • [44] Week 48 results from a phase IIb trial of GNbAC1 in patients with relapsing remitting multiple sclerosis (CHANGE-MS; clinical trial assessing the HERV-W Env antagonist GNbAC1 for Efficacy in MS).
    Hartung, H. P.
    Selmaj, K.
    Glanzman, R.
    Curtain, F.
    Porchet, H.
    Schneble, H-M
    Lambert, E.
    Barkhof, F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 51 - 52
  • [45] Week 24 results from a Phase IIb trial of GNbAC1 in patients with relapsing remitting multiple sclerosis (CHANGE-MS; Clinical trial assessing the HERV-W Env antagonist GNbAC1 for Efficacy in MS)
    Hartung, H-P.
    Curtin, F.
    Schneble, H-M.
    Pochet, H.
    Glanzman, R.
    Lambert, E.
    Selmaj, K.
    Barkhof, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 980 - 981
  • [46] Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil
    Pereira, Jessica Goncalves
    Leon, Luciane A. Amado
    de Almeida, Nathalia Alves Araujo
    Raposo-Vedovi, Jessica Vasques
    Fontes-Dantas, Fabriïcia Lima
    Farinhas, Joao Gabriel Dib
    Pereira, Valeria Coelho Santa Rita
    Alves-Leon, Soniza V.
    de Paula, Vanessa S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 76
12345